This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hiroshi Yari: Innovator in Pharmaceutical Chemistry
Introduction
Hiroshi Yari is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. His work focuses on the antagonism of the NPY Y5 receptor, which is crucial in various physiological processes.
Latest Patents
Hiroshi Yari holds a patent for "Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism." This invention discloses novel piperidine and pyrrolidine derivatives that exhibit NPY Y5 receptor antagonistic activity. The patent details a compound represented by a specific formula, which includes various substituents and structural components that enhance its pharmacological properties.
Career Highlights
Hiroshi Yari is associated with Shionogi Company Limited, a prominent pharmaceutical company known for its innovative research and development. His work at Shionogi has allowed him to explore and develop new therapeutic agents that can address unmet medical needs.
Collaborations
Hiroshi has collaborated with talented coworkers, including Hitomi Araki and Masahiro Sakagami. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.
Conclusion
Hiroshi Yari's contributions to pharmaceutical chemistry, particularly through his patent on NPY Y5 receptor antagonists, highlight his role as an innovator in the industry. His work continues to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile